Periodic Reporting for period 2 - IPUD (An Implantable Peritoneal Ultrafiltration Device that actively and continuously prevents fluid overload in congestive heart failure patients)
Reporting period: 2020-09-01 to 2022-07-31
Paragate has developed a unique Implantable Peritoneal Ultrafiltration Device (IPUD) to improve the quality of life and health of diuretic resistant CHF patients. IPUD is a minimally invasive and fully implantable device, serving as a mechanical bypass to the kidneys, that monitors fluid overload and prevents fluid congestion by actively, continuously and non-aggressively remove excess fluid from the body, to keep patients balanced at home.
Foreseen objectives of the proposed project include miniaturization of the implantable system; optimization of system performance; upgrade of the treatment management platform to improve robustness and usability; and clinical validation to demonstrate safety and efficacy of the system to pursue CE Marking.